文献速递角膜与眼表疾病

Zeb1 介导小鼠角膜内皮损伤诱导的间质转化

Zeb1 Mediates Injury-Induced Mesenchymal Transition in the Mouse Corneal Endothelium In Vivo.
PubMed 文献 · Am J Ophthalmol · 2026-06-21

研究利用 Zeb1flox/flox:UBC-CreERT2 小鼠,在体内条件性靶向角膜内皮 Zeb1,发现可抑制 Fgf2 及手术损伤诱导的间质转化相关基因表达和 E-cadherin 抑制,并减轻损伤所致角膜水肿和纤维性后角膜膜形成。

要点

  • 条件性靶向 Zeb1 可抑制 Fgf2 诱导的角膜内皮间质转化相关基因表达。
  • 靶向 Zeb1 显著减轻手术损伤所致小鼠角膜水肿。
  • 靶向 Zeb1 抑制损伤依赖的纤维性后角膜膜形成。

核心结论

  • ZEB1 信号可作为抑制后角膜膜形成和前段纤维化的靶点,有望用于治疗某些不依赖移植的角膜盲。

研究设计与样本

  • 生成 Zeb1flox/flox:UBC-CreERT2 小鼠,通过前房注射 4-羟基他莫昔芬实现角膜内皮 Zeb1 的时空条件性靶向,在体内研究其在角膜内皮中的作用。

主要发现

  • 前房注射 4-羟基他莫昔芬抑制 Zeb1flox/flox:UBC-CreERT2 小鼠角膜内皮中 Fgf2 诱导的 Zeb1 mRNA 和蛋白表达。
  • 条件性靶向 Zeb1 抑制 Fgf2 及手术损伤依赖的间质转化相关基因表达和 E-cadherin 抑制。
  • 手术损伤致角膜水肿,中央角膜厚度为 189.0 ± 14.6 µm(损伤组)vs 92.3 ± 2.8 µm(对照组)。
  • Zeb1 靶向减轻损伤诱导的角膜水肿,中央角膜厚度为 182.2 + 15.5 µm(损伤组)vs 106.8 ± 11.1 µm(损伤+4-羟基他莫昔芬组),F = 120.9,P < .00001。
  • 条件性靶向 Zeb1 抑制体内小鼠角膜内皮损伤依赖的后角膜膜形成。

临床怎么用

  • ZEB1 信号可能作为抑制后角膜膜形成和前段纤维化的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the role of Zeb1 in regulating fibrosis in endothelial-mesenchymal transition (MT) in the cornea. siRNA knockdown of Zeb1 inhibits FGF2-induced MT in the corneal endothelium. Endothelial cells that undergo MT show increased expression of endothelial-MT-associated genes, including COL1, fibronectin, and vimentin, and decreased expression of E-cadherin, leading to fibrous retrocorneal membrane formation. METHODS: To address potential off-target effects of siRNA knockdown, Zeb1flox/flox:UBC-CreERT2 mouse was generated to allow for spatiotemporal control of Zeb1 targeting and studying the role of Zeb1 in the corneal endothelium in vivo. RESULTS: Intracameral injection of 4-hydroxytamoxifen inhibited Fgf2-induced expression of Zeb1 mRNA and protein in the corneal endothelium of Zeb1flox/flox:UBC-CreERT2 mouse. Fgf2 and surgical injury-dependent expression of MT-related genes and suppression of E-cadherin were inhibited by conditional targeting of Zeb1 in the mouse corneal endothelium in vivo. Surgical injury led to corneal edema with a central corneal thickness of 189.0 ± 14.6 µm (injury) vs 92.3 ± 2.8 µm (control), and injury-induced edema was significantly attenuated by Zeb1 targeting in the corneal endothelium with a central corneal thickness of 182.2 + 15.5 µm (injury) vs 106.8 ± 11.1 µm (injury + 4-hydroxytamoxifen), F = 120.9, P < .00001. Moreover, conditional targeting of Zeb1 also inhibited injury-dependent retrocorneal membrane formation in the mouse corneal endothelium in vivo. CONCLUSIONS: These results suggest that ZEB1 signaling could be targeted for inhibiting retrocorneal membrane formation and anterior segment fibrosis and could be leveraged to treat certain forms of corneal blindness without relying on transplantation.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Heur M, Brabletz S, Stemmler MP, et al. Zeb1 Mediates Injury-Induced Mesenchymal Transition in the Mouse Corneal Endothelium In Vivo. Am J Ophthalmol. 2026. PMID: 42323978. doi:10.1016/j.ajo.2026.06.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。